HSCT patient and allograft characteristics
| Patient no. . | Age, y . | Disease . | Donor . | HLA-match . | PBSC versus BM . | ATG or anti-CD52 . | TCD method . |
|---|---|---|---|---|---|---|---|
| 1 | 31 | MDS | URD | 9/10 C | PBSC | Yes | CD34+ selection |
| 2 | 46 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
| 3 | 8 | AML | Sibling | 10/10 | BM | No | SBA-E-BM |
| 4 | 19 | Pre-B ALL | URD | 10/10 | PBSC | Yes | CD34+ selection |
| 5 | 54 | AML | URD | 9/10 DQ | PBSC | Yes | CD34+ selection |
| 6 | 5 | AML | URD | 8/10 A,C | BM | Yes | SBA-E-BM |
| 7 | 55 | CML | Sibling | 10/10 | PBSC | No | CD34+ selection |
| 8 | 58 | CML | Sibling | 10/10 | PBSC | No | CD34+ selection |
| 9 | 56 | AML | URD | 9/10 B | PBSC | Yes | CD34+ selection |
| 10 | 15 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
| 11 | 48 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
| 12 | 29 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
| 13 | 67 | AML | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
| 14 | 59 | MDS | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
| 15 | 38 | AML | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
| 16 | 59 | AML | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
| Patient no. . | Age, y . | Disease . | Donor . | HLA-match . | PBSC versus BM . | ATG or anti-CD52 . | TCD method . |
|---|---|---|---|---|---|---|---|
| 1 | 31 | MDS | URD | 9/10 C | PBSC | Yes | CD34+ selection |
| 2 | 46 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
| 3 | 8 | AML | Sibling | 10/10 | BM | No | SBA-E-BM |
| 4 | 19 | Pre-B ALL | URD | 10/10 | PBSC | Yes | CD34+ selection |
| 5 | 54 | AML | URD | 9/10 DQ | PBSC | Yes | CD34+ selection |
| 6 | 5 | AML | URD | 8/10 A,C | BM | Yes | SBA-E-BM |
| 7 | 55 | CML | Sibling | 10/10 | PBSC | No | CD34+ selection |
| 8 | 58 | CML | Sibling | 10/10 | PBSC | No | CD34+ selection |
| 9 | 56 | AML | URD | 9/10 B | PBSC | Yes | CD34+ selection |
| 10 | 15 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
| 11 | 48 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
| 12 | 29 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
| 13 | 67 | AML | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
| 14 | 59 | MDS | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
| 15 | 38 | AML | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
| 16 | 59 | AML | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
SBA-E-BM indicates T-cell depletion by bone marrow soybean agglutination with sheep red blood cell (RBC) rosetting; URD, unrelated donor; PBSC, peripheral blood stem cell collection; BM, bone marrow; AML, acute myelogenous leukemia; CML, chronic myelogenous leukemia; MDS, myelodysplastic syndrome; and ALL, acute lymphoblastic leukemia.